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Exogenous WNT5A and WNT11 proteins
rescue CITED2 dysfunction in mouse
embryonic stem cells and zebrafish
morphants
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Abstract
Mutations and inadequate methylation profiles of CITED2 are associated with human congenital heart disease (CHD).
In mouse, Cited2 is necessary for embryogenesis, particularly for heart development, and its depletion in embryonic
stem cells (ESC) impairs cardiac differentiation. We have now determined that Cited2 depletion in ESC affects the
expression of transcription factors and cardiopoietic genes involved in early mesoderm and cardiac specification.
Interestingly, the supplementation of the secretome prepared from ESC overexpressing CITED2, during the onset of
differentiation, rescued the cardiogenic defects of Cited2-depleted ESC. In addition, we demonstrate that the proteins
WNT5A and WNT11 held the potential for rescue. We also validated the zebrafish as a model to investigate cited2
function during development. Indeed, the microinjection of morpholinos targeting cited2 transcripts caused
developmental defects recapitulating those of mice knockout models, including the increased propensity for cardiac
defects and severe death rate. Importantly, the co-injection of anti-cited2 morpholinos with either CITED2 or WNT5A
and WNT11 recombinant proteins corrected the developmental defects of Cited2-morphants. This study argues that
defects caused by the dysfunction of Cited2 at early stages of development, including heart anomalies, may be
remediable by supplementation of exogenous molecules, offering the opportunity to develop novel therapeutic
strategies aiming to prevent CHD.
Introduction
Despite clinical improvements and efforts to sensitize
the population about heart disease risk factors and habits
for prevention, the global burden of cardiovascular disease
has increased worldwide1. Congenital heart disease
(CHD) affects nearly 1% of new-borns and results from
structural and functional cardiac anomalies occurring
during pregnancy due to genetic and/or environmental
causes. Significant progress in the comprehension of
genetic causes has already been achieved through basic
and clinical cardiovascular research2,3. Genetic screens of
large cohort of patients worldwide have led to the iden-
tification of non-synonymous and synonymous variants in
CITED2 sequence associated with sporadic non-
syndromic CHD4–10. In mouse models, Cited2 knockout
embryos died in utero with cardiac abnormalities resem-
bling those commonly observed in children with
CHD11–19. Ventricular (VSD) and atrial (ASD) septal
defects, transposition of the great arteries and the tetral-
ogy of Fallot (TOF) are the most frequent heart anomalies
associated with CITED2 variants in humans. Remarkably,
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most of the missense mutations clustered in the serine
rich junction (SRJ) domain which is unique to CITED220.
Most of CITED2 variants identified in patients with CHD,
only marginally affect the capacity of CITED2 to repress
HIF-1α transcriptional activity and/or to co-activate
TFAP2C transcription factor ex vivo4–10. CITED2 muta-
tions in patients may also result in severe impairment of
the vascular endothelial growth factor (VEGF) and
PITX2C expression which are, respectively, involved in
normal development of the vasculature, and left-right
patterning, as well as heart development8. CITED2 var-
iants identified within the 5ʹ and 3ʹ-untranslated regions
associated with ASD, VSD, and TOF4, may result in
abnormal stability, processing, localization or translation
of the CITED2 transcripts, and consequently decrease
CITED2 protein expression. In addition, reduced CITED2
expression levels and an abnormal hypermethylation of
CpG islands at its promoter have also been correlated
with CHD7. Thus, like in mouse embryos in which Cited2
is haplodinsufficient13, a reduced expression of functional
CITED2 during gestation may result in CHD in humans.
During gastrulation, the expression of Brachyury marks
all cells of the mesoderm, then Mesp1 is subsequently
expressed in early cardiac mesoderm cells, which will
specify into cardiac cells of the first and second heart
fields that contribute to the bulk of the adult heart21. In
mouse embryos, Cited2 deletion in either BRACHYURY-
expressing or MESP1-expressing cells did not overtly
affect heart development and viability11, arguing that
Cited2 may play a role in cardiogenesis before mesoderm
specification. Accordingly, mouse embryonic stem cells
(ESC) are only markedly impaired for cardiac specification
when Cited2 is depleted at the onset of differentiation22.
Cited2 depletion at day 2 of differentiation, before
mesodermal specification, has a marginal effect on car-
diogenesis, while its depletion after mesoderm specifica-
tion from day 4 of differentiation onwards, fails to overtly
affect cardiac differentiation22. Cited2-depletion at the
onset of differentiation downregulated the expression of
early mesoderm and cardiogenic specifying genes, such as
Brachyury, Mesp1, Isl1, Gata4, Nkx2.5, Tbx5, and
Nfat322,23. Heart development and ESC differentiation
towards cardiac cell lineages also rely on the sequential
and cooperative modulation of signaling pathways, such
as the canonical and non-canonical Wnt, bone morpho-
genetic proteins (Bmp), Activin/Nodal, Fibroblast growth
factors (Fgf), Notch and Hedgehog pathways. The Wnt/
β-catenin canonical pathway is essential to exit the plur-
ipotency state and for mesoderm specification, and its
subsequent inhibition is required for the transition of
mesoderm cells to cardiac progenitors and cardiomyo-
cytes24,25. The biphasic regulation of the Wnt/β-catenin
signaling pathway is orchestrated by secreted Frizzled‐
related protein (sFRP) and Dickkopf1 (DKK1) antagonists,
and by the action of Wnt non-canonical proteins, such as
WNT5A and WNT1124–26.
To better understand the role of Cited2 in early car-
diogenic program, we employed microarray technology to
identify the global transcriptional changes associated with
Cited2-depletion at the onset of ESC differentiation. The
analysis of gene expression profiles suggested a delay in
mesoderm commitment and cardiac specification in
Cited2-depleted cells, as well as the suboptimal expression
of many modulators of signaling pathways and secreted
factors critical for cardiogenesis. We show that the car-
diogenic defects of Cited2-depleted ESC are amendable by
supplementation of conditioned medium obtained from
ESC overexpressing CITED2 or treatment with recombi-
nant WNT5A and WNT11 proteins at the onset of dif-
ferentiation. Finally, we provide evidence that CITED2,
WNT5A and WNT11 recombinant proteins have the
potential to rescue the developmental defects, including
heart defects, and mortality caused by cited2 depletion in
zebrafish embryos.
Materials and methods
Zebrafish rearing, embryo generation and microinjection
of morpholinos
The night before injection, adult zebrafish (AB) males
and females were set up in breeding tanks separated by
dividers to increase total egg production. Next morning,
males and females were allowed to mate naturally and
embryos were immediately collected after fertilization,
and microinjected at one-cell stage with 4.6 nl containing
5 ng (~0.7 pmol) of the custom designed Cited2 Mor-
pholino CCATCATGCGGTCTACCATTCCC with a 3'-
Carboxyfluorescein end modification which targeted the
translational start site (UAG MO), a cited2 Morpholino
AACTTTGTAACCTTTACCTCTCCGC with 3'-Lissa-
mine end modification targeting the splicing site in the
exon 1 (SPLICING MO), or a combination of both 2.5 ng
UAG MO and 2.5 ng of SPLICING MO prepared in 1×
Danieau solution (58 mM NaCl, 0.7 mM KCl, 0.4 mM
MgSO4, 0.6 mM Ca(NO3)2, and 5.0 mM HEPES, pH 7.6).
Similarly, a standard non-targeting oligonucleotide
CCTCTTACCTCAGTTACAATTTATA (Control MO)
was also microinjected to control the procedures. All
morpholinos were acquired from GeneTools. Zebrafish
embryos were kept in embryo medium (E3 medium
supplemented with penicillin/streptomycin to a final
concentration of 10 units/ml penicillin and 100 µg/ml
streptomycin) at 28.5 °C with a photoperiod of 14 h light
and 10 h dark. The medium was changed every day and
the dead embryos counted and discarded. For heart rate
determination, the number of heart beats were counted
from 10 s videos of hearts acquired from randomly picked
embryos at 48 hpf. Live imaging and photography were
captured on a Leica MZ 7.5 stereomicroscope (Leica
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Microsystems). All experiments were conducted in
accordance with the regulation of the Directive 2010/63/
EU (EU, 2010).
Embryonic stem cells, culture conditions production of
conditioned medium, and transient transfections
C2Δ/Δ[LA11], C2fl/fl[Cre] and E14/T mouse ESC lines
were previously described, and were cultured on gelatine-
coated plates in undifferentiating medium supplemented
with LIF22,27. Differentiation was induced using the
hanging-drop method in medium containing 10% FBS
without LIF supplementation (differentiation medium) as
previously described22, except otherwise indicated. For
conditioned media production, undifferentiated E14/T
ESC transfected with an episomal vector expressing a flag-
tagged human CITED2 (E14T/flagCITED2) or the pPy-
CAGIP control vector (E14T/Control) were cultured at a
density of 3 × 104 cells/cm2 in undifferentiating conditions
on 0.1% gelatine-coated 100 mm culture plates for 24 h as
described elsewhere22,27. Next, cells were washed twice
with PBS1× and subsequently cultured in plain GMEM
medium (no supplements added) at 37 °C in a 5% CO2
incubator for 16 h. Resulting conditioned media collected
either from E14T/flagCITED2 cultures (termed CM-
CITED2 hereafter) or E14T/Control cultures (termed
CM-Ctl hereafter) was filtered through 0.45 μm. For
transient transfections E14/T cells were co-transfected
with the with Wnt11-luc reporter plasmid (harboring a
1064 bp fragment of mouse Wnt11 proximal promoter
region) described elsewhere28, with either the flag-
CITED2 expressing plasmid or the control vector pPy-
CAGIP, as previously described27.
In vitro and in vivo rescue experiments
For rescue experiments, CM-Ctl or CM-CITED2 was
mixed to the differentiation medium described above in a
1:1 proportion with 10% FBS final. The mix differentiation
media were used only at the onset of C2fl/fl[Cre] ESC
differentiation (Day 0, D0) for 48 h, concomitantly with
the supplementation of 4 hydroxytamoxifen (4HT) at
1 μM final concentration or ethanol used as vehicle. The
rest of the differentiation process was performed as
described above. For the rescue experiments using
Wnt5a-depleted or Wnt11-depleted CM-CITED2, 1.5 ml
of conditioned medium, obtained from E4T/flagCITED2
cells prepared as described above, was incubated either
with 5 μg of either rat monoclonal anti-Wnt5a (MAB645,
R&D Systems) or rabbit polyclonal anti-Wnt11 (SC-
50360, Santa Cruz) antibodies at 4 °C for 16 h. Next, the
immunocomplexes were purified using 30 μl (50% wt/vol)
Protein G sepharose beads suspension (GE Healthcare),
pre-blocked with 1% BSA solution added to CM-CITED2
and incubated at 4 °C with agitation for 1 h. The immu-
nocomplexes bound to the protein G sepharose beads
were centrifuged out and used for western blotting as
described below, while the remaining media CM-CITED2
depleted from Wnt5a or Wnt11 was used in C2fl/fl[Cre]
ESC differentiation assays. Alternatively, secreted Wnt5a
or Wnt11 proteins in the CM-CITED2 were blocked
during differentiation by adding either 5 μg/ml of rat
monoclonal anti-Wnt5a (MAB645, R&D Systems) or
2.5 μg/ml of rabbit polyclonal anti-Wnt11 (SC-50360,
Santa Cruz) antibodies to the differentiation medium of
C2fl/fl[Cre] ESC during the first 48 h of differentiation.
The control experiments were performed with no addi-
tion of any antibody or by addition of 5 μg/ml of rabbit
anti-IgG.
Mouse recombinant Wnt5a (rWnt5a) protein (GF146,
Millipore) and human recombinant Wnt11 (rWnt11)
protein (6179-WN, R&D Systems) reconstituted in PBS1×
with 0.1% BSA, were supplemented either individually
at 100 ng/ml or in combination at 50 ng/ml each, at
the onset of C2fl/fl[Cre] ESC treated with 4HT or
C2Δ/Δ[LA11] ESC differentiation for 48 h. For rescue of
Zebrafish defects, the indicated amounts of rWnt5a and
rWnt11 were microinjected at one-cell stage con-
comitantly with anti-Cited2 morpholinos. The 8R-
CITED2 recombinant protein (full-length human
CITED2 protein fused at its N-terminal domain to 8
arginines) production and purification was described
elsewhere22. Prior to microinjection of 8R-CITED2 at
one-cell stage concomittantly with anti-Cited2 morpho-
linos, the 8R-CITED2 protein samples were dialyzed using
SnakeSkin Dialysis Tubing 3.5 k MWCO (Thermofisher),
against PBS1X at 4 °C for 16 h to remove the phe-
nylmethylsulfonyl fluoride (PMSF) serine protease inhi-
bitor used during its production. 400 or 500 pg (~13.5 or
16.7 fmol) of 8R-CITED2 were microinjected as indicated.
ESC differentiation and microarray data generation
The differentiation of C2fl/fl[Cre] ESC was performed by
the hanging drop method in the presence of 1 μM 4HT or
ethanol supplemented at the onset of the process as
described previously22. The assessment and counts of
beating foci in culture plates were performed as previously
described22. For microarray studies, undifferentiated
C2fl/fl[Cre] ESC (treated with ethanol for 48 h, corre-
sponding to the onset of differentiation-D0) and
C2fl/fl[Cre] ESC differentiated by hanging drop/embryoid
bodies formation until D4 after ethanol or 4HT treatment
for 48 h at the onset of differentiation were collected.
RNA preparation, microarray hybridization to Mouse
Genome 430 2.0 arrays (Affymetrix), as well as quality
control of matrices, raw data background correction,
summary and normalization of microarray data, and a
PCA to evaluate transcriptomic variability between the
samples obtained from ESC at D0 and differentiated cells
at D4 upon treatment of ethanol or 4HT were performed
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as previously described29. Differential expression was
determined through application of an empirical Bayes
linear model, and the significance of the changes was
adjusted using Benjamini–Hochberg method, with
adjusted p < 0.05 considered statistically significant. After
standardization of signal values to a mean of 0 and
standard deviation (SD) of 1 significant probe sets were
analyzed by k-mean clustering based on Euclidian dis-
tance measurement and k= 7 using the Cluster 3.0 tool.
Gene ontology (GO) and KEGG pathway analysis was
conducted using Enrichr30,31, and top enriched biological
process terms were presented.
Protein preparation, immunoprecipitation and western
blotting
The immunocomplexes bound to the protein G
sepharose beads obtained from CM-CITED2 and CM-Ctl
as described above, were washed 5 times with PBS1× and
immunopurified proteins were analyzed by western blot
as previously described27, with a rat monoclonal anti-
WNT5A (MAB645, R&D Systems) or rabbit polyclonal
anti-WNT11 (SC-50360, Santa Cruz) antibodies used at
1:1000 and 1:200 dilution, respectively. Loading was
monitored by staining of PVDF membrane-bound pro-
teins by ponceau s. Western blotting assays performed
using 15 μg of protein extracts from zebrafish embryos
harvested at 24 and 48 hpf after microinjection of either
combined AUG and SPLICING (2.5 ng of each morpho-
lino) or non-injected the control embryos (Control) pre-
pared using conditions previously described27. Proteins
were separated by SDS-PAGE on TGX Stain-Free™ Fas-
tCast™ Acrylamide Kit (Bio-Rad). CITED2 protein was
detected in zebrafish extracts using an anti-CITED2 rat
monoclonal IgG2A antibody (MAB5005, R&D System)
used at 1:500 dilution as recommended by the manu-
facturer. Loading control was monitored by detection of
total stained proteins transferred to the PVDF membrane.
Quantitative real-time PCR (qPCR)
Total RNA isolation, complementary DNA synthesis
and qPCR assays were carried out as previously descri-
bed22,27, with primers listed in Supplemental Table S3.
Statistical analysis
Statistical significance was determined via two-tailed
Student’s t tests assuming unequal variance or using
Fisher’s exact test of independence for more than 2
nominal variables, as indicated. p values < 0.05 were
considered statistically significant.
Results
Delayed mesoderm commitment of Cited2-depleted cells
To investigate the mechanisms underlying the cardio-
genic defects of Cited2-depleted ESC, we compared gene
expression profiles at day 4 (D4) of differentiation of cells
derived from C2fl/fl[Cre] ESC treated at the onset of dif-
ferentiation for 48 h either with 4-hydroxytamoxifen
(4HT) to deplete Cited2 or with ethanol (vehicle), as
previously described22. The gene expression profile of
undifferentiated C2fl/fl[Cre] ESC (D0) treated for 48 h with
ethanol was also established (Fig. 1a). The principal
component analysis indicated that gene expression pat-
terns of cells at D0, control and Cited2-depleted cells at
D4 of differentiation are distinct (Fig. 1b). The analysis of
gene expression profiles with a significant differential
expression (adjusted p value < 0.05) and a positive or
negative log2 fold-change >1.2 was performed between
samples. Comparison of differentially expressed genes
(DEGs) between control cells at D0 and D4 of differ-
entiation was performed (Table S1). In addition, the
functional enrichment analysis for these DEGs using
Enrichr30,31, indicated that many upregulated genes at D4
of differentiation are related to cardiovascular develop-
ment, and epithelial-to-mesenchymal transition (EMT)
which is an early event of ESC commitment to mesoderm
(Fig. S1). Fewer genes were differentially expressed
between ESC at D0 and Cited2-depleted cells at D4 of
differentiation (Table S2). The analysis of DEGs between
Cited2-depleted and control cells at D4 of differentiation,
revealed 263 upregulated and 334 downregulated genes
(Table S2). Functional enrichment analysis for genes
upregulated in Cited2-depleted cells at D4 of differentia-
tion did not pinpoint any biological process with statis-
tical significance (Table S2). However, this set contains
genes associated with pluripotency, such as Nanog, Klf2,
Klf4, Klf5, Zfp42/Rex1, Sox2, Esrrb, Nr0b1, Dppa5a, and
Zfp462 (Table S2), arguing for a delayed or restrained
differentiation potential of Cited2-depleted ESC. We also
compared the set of genes upregulated in Cited2-depleted
cells with publicly available transcriptomics datasets
related to stem cells using StemMapper32. This analysis
confirmed that upregulated genes at D4 of differentiation
in Cited2-control cells distinguish between different cell
lineages (Fig. S1c). Compared to controls, Cited2 deple-
tion results in the loss of distinction between pluripotent,
cardiac and neural lineages, suggesting further that
Cited2-depleted cells are less differentiated. Interestingly,
profiles of blood cell lineages remained distinct for
Cited2-depleted and control cells. The analysis of biolo-
gical processes enriched terms for genes downregulated in
Cited2-depleted cells at D4 of differentiation indicated
that Cited2 regulates the expression of genes critical for
many aspects of cardiovascular, kidney and endoderm
development, mesoderm formation and angiogenesis
(Fig. 1c and Table S2). Notably, Brachyury, Mesp1, Isl1,
and Gata4 identified in this set of genes were previously
described to be affected by Cited2 depletion in ESC22,23.
To further validate the microarray data, we established a
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Fig. 1 Cited2 depletion in embryonic stem cells delays mesoderm commitment. a Timeline depicting the protocol (embryoid bodies (EB)
formation) used for differentiation C2fl/fl[Cre]ESC from D0 to D4. The time of ethanol or 4HT treatment is indicated. Undifferentiated control ESC
(Undiff.) were treated with ethanol for 2 days. b Principal Component Analysis (PCA) of the entire normalized array datasets. After normalization of the
entire transcriptome dataset obtained from undifferentiated C2fl/fl[Cre]ESC treated with ethanol (Undiff. D0/Ethanol) and differentiated for 4 days
upon treatment with ethanol (D4/Ethanol) or 4HT (D4/4HT) for the first 48 h. Each sphere represents and individual sample. PC1 shows the main
variability among the transcriptome differences and PC2 shows the second largest variability. c Top15 gene ontology biological process terms for the
genes down-regulated by Cited2 depletion at D4 of differentiation determined using Enrichr. d Top10 KEGG pathway terms for the genes
downregulated by Cited2 depletion at D4 of differentiation determined using Enrichr. e Expression of the epiblastic (Fgf5) and mesoderm (Brachyury,
Mixl1, Mesp1, and Eomes) markers from D1 to D6 of differentiation in cells generated from C2fl/fl[Cre] ESC treated with ethanol or 4HT as described in
a. Results are presented as the mean ± SEM of three independent biological experiments
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time course of expression for genes associated with
pluripotency (Dppa5a), epiblast state/ectoderm (Fgf5),
primitive streak/mesendoderm specification (Brachyury,
Mixl1, Mesp1, Eomesodermin (Eomes), Cer1, and Gsc) and
secreted molecules (Bmp4, Bmp5, and Wnt3) promoting
ESC differentiation (Fig. 1e and Fig. S2a). Overall, we
confirmed that Brachyury, Mixl1, Mesp1, Eomes, and Cer1
expression was decreased in Cited2-depleted cells at D4 of
differentiation. However, the time course analysis from
D1 to D6 of differentiation indicated that their expression
peaked at D5 in Cited2-depleted cells, which is a day later
than control cells. Moreover, at D5-D6 of differentiation
Fgf5, Brachyury, Mixl1, Mesp1, Eomes, Cer1, and Gsc
expression remained higher in Cited2-depleted cells.
Together, our results suggest that Cited2 depletion
delayed mesoderm differentiation.
Cited2 depletion affects the expression of cardiopoietic
factors
The analysis of enriched pathway terms also suggested
that Cited2 depletion affected the expression of mod-
ulators of signaling pathways normally under a tight
regulation to instruct cell fate decisions25. Indeed, Bmp2,
Bmp5, Bmp7, Bmper, Fgf3, Fgf8, and Fgf10 expression was
downregulated in Cited2-depleted cells, while Fgf4
expression was increased (Fig. 1c, d and Table S2). In
addition, several genes encoding for secreted or
membrane-bound proteins which are either antagonists of
the Wnt canonical pathway such as Frzb, Dkk1, Wnt5a,
Cer1, Apcdd1 or agonists such as Rspo3, Wnt2, Wnt2b,
and Wnt3 were amongst the most affected genes by
Cited2-depletion (Table S2). Thus, cardiogenic defects of
Cited2-depleted ESC may also result from the dysregu-
lation of these signaling pathways.
To investigate whether CITED2 promoted the secretion
of cardiopoietic factors, we transfected as previously
described22,27, undifferentiated E14/T ESC with a control
(E14T/Control) or flag-CITED2 expressing plasmid
(E14T/flagCITED2). Next, these ESC were maintained for
16 h in medium deprived of LIF and serum (to prevent
confounding effects of cardiogenic factors contained in
the serum) for the preparation of conditioned medium
(CM) enriched with ESC-secreted proteins. CM collected
either from E14T/Control (CM-Ctl) or E14T/flagCITED2
(CM-CITED2) cultures were used to supplement the
differentiation medium of C2fl/fl[Cre] ESC (Fig. 2). CM
was supplemented at the onset of differentiation for 48 h,
concomitantly with 4HT to deplete Cited2 or ethanol
treatment (Fig. 2a). As expected, the number of beating
which are indicative of cardiomyocyte spontaneous con-
tractile activity, was reduced in cell cultures derived from
Cited2-depleted ESC differentiated in 4HT/CM-Ctl in
comparison to control cells (Ethanol/CM-Ctl), particu-
larly at D9–D10 (Fig. 2b). Noticeably, not only the number
of EB with spontaneous contractile activity was reduced in
cells differentiated with 4HT/CM-Ctl, but the number of
beating foci per EB was also decreased (Fig. 2b).
Remarkably, the number of beating foci was similar in
cultures derived from Cited2-depleted ESC differentiated
in 4HT/CM-CITED2 and cultures of control conditions
(Ethanol/CM-Ctl). CM-CITED2 supplementation did not
alter the number of beating foci emerging in cells nor-
mally expressing Cited2 (Ethanol/CM-Ctl compared to
Ethanol/CM-CITED2). Interestingly, the supplementation
of CM-CITED2 to Cited2-depleted cells stimulated Bra-
chyury expression at D4 of differentiation without
affecting significantly the expression of Cited2, Mesp1,
Nkx2.5 and Isl1 (Fig. 2c). Thus, molecules secreted by ESC
overexpressing flag-CITED2 may restore normal differ-
entiation process of Cited2-depleted cells as early as
mesoderm specification in a Cited2-independent manner.
WNT5A and WNT11 restore normal cardiac differentiation
of Cited2-depleted cells
To identify potential cardiopoietic factors secreted to
the medium upon overexpression of flag-CITED2, we
assessed Wnt3, Wnt3a, Wnt5a, Wnt5b, Wnt11, Dkk1,
Bmp4, Nodal, Cerl1, Fgf8, and Fgf10 expression by qPCR
in E14T/flagCITED2 and E14T/Control ESC (Fig. 2d).
These genes are essential for early mesoderm induction
and cardiac specification, encoding modulators of Wnt,
Bmp, Tgfβ, and Fgf signaling pathways25. No significant
differences were observed in Bmp4, Nodal and Wnt5b
expression (Fig. 2d). The analysis of microarray data also
indicated that Fgf8 and Cer1 expression may be sensitive
to Cited2 depletion (Table S2). However, only a mild
decrease of Fgf8 and Cer1 expression without statistical
significance was observed by qPCR (Fig. 2e). In contrast,
Wnt5a, Wnt11, Dkk1, and Fgf10 expression was sig-
nificantly increased in cells overexpressing CITED2, while
Wnt3 expression was only marginally altered and Wnt3a
expression reduced (Fig. 2d). The downregulation of
Wnt3a, Wnt5a, Wnt11, Dkk1, and Fgf10 in Cited2-
depleted cells at D4 of differentiation observed in the
microarray data was confirmed by qPCR (Fig. 2e and
Table S1). Thus, Wnt5a, Wnt11, Dkk1, and Fgf10
expression patterns correlated with Cited2 expression
(Fig. 2d, e), arguing for a positive effect of Cited2 on the
expression of these genes. A direct involvement of
CITED2 in their transcriptional regulation remains to be
established. Together, these observations suggested that
the delay in Cited2-depleted ESC differentiation may
result from a defective expression of secreted factors, such
as Wnt5a, Wnt11, and Dkk1.
To determine whether CM-CITED2 contained WNT5A
and WNT11 proteins, and whether these proteins con-
tributed to restore the cardiogenic potential of Cited2-
depleted ESC, we performed a western blotting with plain
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CM-CITED2 and CM-Ctl using specific antibodies
against WNT5A or WNT11. However, no proteins were
detected, suggesting that these molecules were either
absent or in very low quantity in the CM. To enrich the
western blotting samples with WNT5A and WNT11,
proteins from CM-CITED2 and CM-Ctl were immuno-
precipitated using either WNT5A or WNT11 specific
antibodies. Immunopurified proteins were analyzed by
western blotting, which revealed that Wnt5a and Wnt11
proteins were more abundant in CM-CITED2 than
Fig. 2 The secretome of CITED2 overexpression embryonic stem cells rescues cardiac differentiation of Cited2-depleted cells. a Timeline
depicting the protocol used for differentiation C2fl/fl[Cre]ESC from D0 onward. The time of ethanol or 4HT treatment, as well as the supplementation
with the conditioned media, and the days of beating activity assessment are indicated. b Percentage of colonies with contractile foci (top panel)
counted at 8, 9 and 10 days after the initiation of differentiation in cell cultures derived from C2fl/fl[Cre] ESC treated with ethanol or 4HT at D0 of
differentiation, and simultaneously supplemented with conditioned medium either from control cells (Ethanol/CM-Ctl and 4HT/CM-Ctl, respectively)
or from cells overexpressing CITED2 (Ethanol/CM-CITED2 and 4HT/CM-CITED2, respectively). The number of beating foci per beating colony is also
indicated (bottom panel). c Relative expression of Cited2, Brachyury, Mesp1, Nkx2.5, and Isl1 determined by qPCR at D4 of differentiation in cultures
derived from C2fl/fl[Cre] ESC treated with 4HT either in the presence of and CM-Ctl or CM-CITED2 as described in b. The expression of the indicated
genes is presented as the fold of expression in cells treated with CM-CITED2 over cells treated with CM-Ctl. The black bars indicate variations without
reaching statistical significance, and gray bars indicate genes with statistical significance by Student’s t-test. NS, not significant. d Relative expression
of the indicated genes encoding secreted proteins involved in cardiogenesis, determined by qPCR in E14/T ESC transfected with a plasmid
expressing flag-tagged CITED2 (flagCITED2) or the control empty plasmid (control cells). The results are presented as in c. e Expression of the
indicated genes encoding secreted proteins involved in cardiogenesis, in cells treated as described in c. The results are presented as in c. Results are
presented as the mean ± SEM of three independent biological experiments
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CM-Ctl (Fig. 3a). In addition, Wnt5a and Wnt11 tran-
scripts expression was markedly impaired in Cited2-
depleted cells during differentiation (Fig. 3b). Con-
cordantly, we showed that the overexpression of flag-
CITED2 in E14/T cells stimulated the activity of Wnt11
promoter (Fig. s2b), arguing that Wnt11 expression may
be under the direct control of CITED2 regulation. Next,
we used CM-CITED2 and CM-Ctl depleted either from
WNT5A or WNT11 proteins by immunoprecipitation in
differentiation assays (Fig. 3c). Unlike control CM-
CITED2, WNT5A or WNT11 immuno-depleted CM-
CITED2 failed to restore the emergence of beating foci to
the level of control cells (Fig. 3c). Direct supplementation
of antibodies against WNT5A or WNT11 to CM-CITED2
at the onset of differentiation also neutralized the rescue
(Fig. S2c). Altogether, these observations indicated that
secreted WNT5A and WNT11 proteins compensate for
the loss of Cited2 in early events of ESC cardiac differ-
entiation. These observations were corroborated by the
ability of recombinant WNT5A (rWnt5a) and WNT11
(rWnt11) proteins to complement the loss of Cited2
function in ESC (Fig. 3d). Individual and combined sup-
plementation of rWnt5a and rWnt11, at the onset of the
process for 2 days, stimulated cardiomyocyte differentia-
tion of Cited2-depleted ESC. However, only the co-
supplementation of rWnt5a and rWnt11 fully restored the
differentiation efficiency to the level of control cells.
Supplementation of rWnt5a and rWnt11 had no sig-
nificant effect on the cardiac differentiation of control
cells (Fig. 3d). Interestingly, rWnt5a/rWnt11 treatment
also significantly stimulated the cardiogenic potential of
Cited2-null C2Δ/Δ[LA11] ESC (Fig. 3e). Therefore, the
potential of rWnt5a/rWnt11 to rescue the cardiogenic
program of Cited2-depleted ESC is independent of
endogenous CITED2 expression/function. Accordingly,
the treatment of Cited2-depleted C2fl/fl[Cre] ESC with
rWnt5a and rWnt11 did not affect Cited2 expression
levels in depleted cells (Fig. 3f). Interestingly, Mesp1 and
Isl1 expression, strongly downregulated in Cited2-deple-
ted cells, was restored to levels comparable to those of
control cells by the combined treatment with rWnt5a/
rWnt11 (Fig. 3f). On the other hand, Brachyury expres-
sion was higher in Cited2-depleted cells treated with
rWnt5a/rWnt11 than in control cells, while Nkx2.5 and
Tbx5 expression was not significantly altered in the same
conditions. Noticeably, the treatment of Cited2-depleted
cells either with only rWnt5a or rWnt11 restored normal
Brachyury expression levels (Fig. 3f). On the other hand,
Mesp1 and Isl1 expression exceeded the levels of control
cells when treated solely with rWnt5a, and Mesp1
expression levels were increased without reaching normal
levels by rWnt11 treatment (Fig. 3f). Interestingly,
WNT5A and WNT11 homodimers have been reported to
physically interact, and their combined exogenous
expression synergizes to regulate normal Xenopus
embryonic patterning, while the expression of either
WNT5A or WNT11 alone inhibit the endogenous Wnt
pathways33. Therefore, the combined supplementation of
rWnt5a/rWnt11 may balance the action of these proteins
to adequately regulate Brachyury, Mesp1, and Isl1
expression during ESC differentiation.
WNT5A and WNT11 restores viability and cardiogenesis to
Cited2-morphants
We next sought to investigate whether the supple-
mentation of Wnt5a and Wnt11 would rescue the
developmental defects caused by Cited2 depletion in vivo.
To this aim, we used zebrafish (Danio rerio), a widespread
animal model to study cardiovascular development34,35.
Zebrafish has a unique cited2 gene which is expressed
from pre-gastrulation stage and across later embryonic
developmental stages36,37. We assessed the role of cited2
in zebrafish development using specific antisense mor-
pholinos targeting either the cited2 mRNA translation
start site (AUG-MO) or the splicing site in the exon 1
(SPLICING-MO) to deplete Cited2 by microinjection at
one-cell stage (Fig. 4a). Depletion of Cited2 protein in
embryos microinjected with AUG/SPLICING-MO was
monitored by western blotting (Fig. S3a). Control animals
were microinjected with a standard non-targeting mor-
pholino (Control-MO). The development and viability of
embryos microinjected with Control-MO did not differ
significantly from non-injected embryos, indicating that
the procedure was not originating developmental defects
(Fig. 4b). Conversely, microinjection of AUG-MO and
SPLICING-MO individually or in combination triggered
the increase of embryonic lethality at 24 hpf in compar-
ison to control embryos (Fig. 4b). Alive embryos micro-
injected with AUG-MO and SPLICING-MO individually
or in combination, display more frequent signs of devel-
opmental delay than control animals (Fig. 4c, d). To
evaluate whether the developmental defects observed in
Cited2-morphants were specifically caused by loss of
Cited2 expression, we performed co-microinjections of
the morpholinos against cited2 with recombinant human
8R-CITED2 protein. This protein which is able to cross
the cellular membranes and reach the nucleus when
applied to the culture medium22, significantly decreased
the number of embryos displaying developmental delays
(Fig. 4d). Thus, the developmental delays of Cited2-
morphants were likely due to loss of Cited2 expression. At
48 hpf, living Cited2-morphants consistently developed
bradycardia (~120–140 beats/min) in comparison to
control embryos which presented a normal heart rate at
~170 beats/min (Fig. 5a). Decrease of heart rate is a sign of
cardiac dysfunction which was further confirmed by the
presence of pericardial effusion and cardiac anomalies
such as linear heart tube, enlarged heart chambers or the
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presence of a virtually unique chamber in Cited2-
morphants (Fig. 5b). At 72 hpf, the cumulative death
rate of Cited2-morphants was significantly increased
compared to control embryos, particularly in embryos
microinjected with both anti-cited2 morpholinos in which
the mortality rate was ~75%. Concomitantly, Cited2-
morphants that survived at 72 hpf displayed cardiovas-
cular anomalies at higher levels than controls (Fig. 5c). In
addition to cardiac abnormalities, Cited2-morphants
often presented a delay in hatching, low mobility, back
curvature and curved tail defects (Fig. s3f). Of interest,
heart rate and cardiovascular defects, as well as lethality
caused by anti-cited2 morpholinos were partially rescued
by the co-microinjection of 8R-CITED2, arguing further
that the remarkable defects observed in the embryos were
specific to Cited2 depletion.
Since we determined that the supplementation of
rWnt5a and rWnt11 to ESC at the onset of differentiation
restored the cardiogenic functions lost by Cited2-deple-
tion, we assessed the ability of these proteins to rescue the
Fig. 3 WNT5A and WNT11 proteins have the potential to surpass Cited2 lack of function in cardiac differentiation. a Conditioned media
obtained from E14/T ESC transfected with the flagCITED2 expressing vector (CM-CITED2) or the control plasmid (CM-Ctl) immunoprecipitated (IP)
with anti-WNT5A and anti-WNT11 antibodies. Ponceau S stained blots on 10% of the input material used for immunoprecipitation show loading
controls. b Time course of Wnt5a and Wnt11 expression determined by qPCR in samples prepared as described in Fig. 1d. c Percentage of colonies
with contractile foci counted at D10 of differentiation in cell cultures derived from C2fl/fl[Cre] ESC treated with ethanol or 4HT at D0 of differentiation,
or with 4HT in differentiation medium supplemented with conditioned medium either from control cells (4HT/CM-Ctl) or from cells overexpressing
CITED2 (4HT/CM-CITED2), or 4HT/CM-CITED2 medium depleted from WNT5A, WNT11 depletion by immunoprecipitation as described in a, or no
depletion using PBS 1× as vehicle (NIL). d Percentage of colonies with contractile foci counted at D8 of differentiation in cell cultures derived from
C2fl/fl[Cre] ESC treated with ethanol or 4HT at the onset of differentiation (vehicle), in the presence of 100 ng/ml of recombinant WNT5A (rWnt5a) or
WNT11 (rWnt11) proteins or simultaneously with rWnt5a and rWnt11 (50 ng/ml of each). e Percentage of colonies with beating foci derived from
C2Δ/Δ[LA11] ESC at D10 of differentiation, in presence of rWnt5a or/and rWnt11, or PBS 1x as described in d. f Relative expression of Cited2, Brachyury,
Mesp1, Isl1, Nkx2.5, and Tbx5 determined by qPCR at D4 of differentiation in cultures derived from C2fl/fl[Cre] ESC treated as indicated in d. Gene
expression in ethanol/vehicle conditions was set to 1. Bars represent mean ± SEM of three independent experiments
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defects of Cited2-morphant embryos. The micro-injection
of rWnt5a and rWnt11 individually or in combination
restored normal developmental timings, normal heart
rate, and reduced the overall mortality and cardiovascular
anomalies of Cited2-morphants (Figs. 4c, 5a, c). Although,
the cumulative death of Cited2-morphants at 72 hpf was
not restored to the level of control animals by the com-
bined microinjection of rWn5a/rWnt11, surviving
embryos presented less frequent heart defects (Fig. 5c). Of
relevance, microinjection of rWnt5a/rWnt11 proteins
Fig. 4 Early developmental defects of Cited2 morphants are reverted by WNT5A and WNT11. a Schematic representation of the experimental
steps and analysis performed with zebrafish embryos. The timings of development are indicated in hours post fertilization (hpf). b Percentage of
embryos which are normal or dead at 24 hpf, after injection of 5 ng (0.7 pmol) of control morpholino (Control MO), anti-cited2 morpholinos targeting
either the transcriptional start site (AUG MO; 5 ng) or the splicing site in the exon 1 (SPLICING MO; 5 ng), simultaneously with AUG MO and SPLICING
MO (AUG+SPLICING MO, 2.5 ng of each morpholino), as well as non-injected embryos (Non-injected). Statistical significance was determined against
control embryos using Student’s t test. c Brightfield images of live embryos showing the representative morphological features of zebrafish embryos
considered as normal (top panel) or delayed in development (bottom panel) at 20 hpf. d Percentage of embryos which are normal or delayed in the
developmental process at 20 hpf, after injection of morpholinos as described in b, in the presence of 400 pg of recombinant CITED2 protein (8R-
CITED2), rWnt5a and rWnt11 alone (5 pg) or in combination (rWnt5a/11) in a final amount of 5 pg (2.5 pg each) or 10 pg (5 pg each), or no treatment
(NIL). In panels, b and d n represents the number of embryos analyzed in each condition in at least 3 independent experiments
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Fig. 5 Supplementation of WNT5A and WNT11 to early embryos rescues the lethality and cardiac defects of Cited2 morphants. a Heart rate
of embryos treated at presented in Fig. 4d measured at 48 hpf at 28 °C. Each dot represents the value obtain for a single embryo. The mean and
standard deviations for each condition are also presented. Statistical significance was determined against control embryos using Student’s t test.
b Brightfield images of live embryos showing a representative morphology at 48 hpf of control embryos and embryos affected with cardiac
anomalies, such as pericardial effusion, linear heart tube, enlarged atrium and/or ventricle. c Percentage of embryos which are normal, dead or
presenting cardiac anomalies at 72 hpf, after injection of morpholinos as described in Fig. 4d, with the exception that 500 pg of CITED2 recombinant
protein were injected. The death rate presented is the cumulative death observed in each condition from 6 to 72 hpf. n represents the number of
embryos analyzed in each condition in at least 3 independent experiments
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alone without cited2-targeting MO did not affect
the development of the embryos in our conditions
(Fig. S3b–e).
Together our observations indicate that the critical loss
of Cited2 function at the onset of cardiac differentiation of
ESC, or in the early steps of zebrafish development may be
surpassed by treatment WNT5A and WNT11 proteins.
Discussion
CITED2 function is critical for normal cardiac devel-
opment in humans and mice. In this report, we establish
that in comparison to control zebrafish embryos, Cited2-
morphant have a high mortality rate and increased fre-
quency of heart anomalies. Like for Cited2-null mouse
embryos6, supplementation of human CITED2 recombi-
nant protein to Cited2-morphants rescued the defects.
Thus, zebrafish is a valid model to study the develop-
mental functions of Cited2. Our observations support a
critical role for CITED2 in cardiac development across
distant vertebrate species.
Distinct subpopulations of Brachyury-expressing
mesoderm cells emerge in a controlled temporal fashion
during ESC differentiation and in vivo38. Unlike the spe-
cification of hematopoietic cells which may occur from all
Brachyury-expressing cells arising from D2.5 to D4 of
ESC differentiation, cells with cardiogenic potential
emerge in a narrow temporal window at D3-D3.5 of dif-
ferentiation38. Evidence from mouse models and in vitro
ESC-based differentiation experiments had suggested that
Cited2 contributes to cardiac development at early stages
of gastrulation or even during the specification of plur-
ipotent cells to mesoderm11,22. During ESC differentiation
Cited2 expression is biphasic, as it declines at D0-D2 of
differentiation and increases from D3 onwards22. Thus,
Cited2 expression at around D2-D3 of differentiation may
be critical to optimally induce cardiac mesoderm specifi-
cation. Here, we show that Cited2-depletion in ESC delays
the expression of mesoderm markers by 24 h and pro-
longed the expression of the epiblastic marker Fgf5. The
capacity of Cited2-depleted ESC to exit the pluripotency
state upon differentiation may not be altered, since the
downregulation of pluripotency-related genes expression
in these cells was comparable to control ESC at D0-D3 of
differentiation22. However, the microarray analysis we
performed suggests that Nanog, Klf2, Klf4, Klf5, Zfp42/
Rex1, Sox2, Esrrb, Nr0b1, Dppa5a, and Zfp462 genes
related to pluripotency remain expressed at higher levels
at D4 of differentiation in Cited2-depleted cells. Thus, the
delay of Cited2-depleted differentiation may be due to the
stabilization of a transition state between primed plur-
ipotent cells and mesoderm cells. A similar phenomenon
was also observed with Strip2-depleted murine ESC39,40.
We have highlighted the importance of Cited2 for
optimal expression of cardiopoietic factors, such as
Wnt5a and Wnt11. Interestingly, during mouse embryos
gastrulation and ESC differentiation, the canonical Wnt
pathway is required for the formation of the primitive
streak and to initiate mesoderm specification. Wnt5a and
Wnt11 expression is important for these early develop-
mental events through the stimulation of EMT41. Secre-
tion of WNT5A, WNT11, and DKK1 is also essential to
inhibit the canonical Wnt pathway and allow mesoderm
cells to originate cardiac progenitors25. Interestingly,
Wnt5a and Wnt11 are expressed during quail and zeb-
rafish development at various stages, including the
induction of mesoderm26,42–45. In human ESC, WNT5A,
and WNT11, by activation of the non-canonical pathway,
regulate cardiac differentiation through mesoderm
induction, activation of MESP1 expression and cardio-
myocyte differentiation46. Interestingly, the decrease of
Brachyury, Mesp1, and Isl1 expression observed in
Cited2-depleted ESC was reverted close to normal levels
by recombinant WNT5A and WNT11 treatment in a
Cited2-independent manner. Thus, impaired cardiac dif-
ferentiation of Cited2-depleted ESC may result from a
defective inhibition of the canonical Wnt/β-catenin
pathway or activation of non-canonical Wnt pathways
causing low expression levels of Brachyury, Mesp1, and
Isl1. Importantly, the supplementation of recombinant
WNT5A and WNT11 proteins truly complemented
CITED2 function in the cardiogenic process of Cited2-
depleted ESC.
Finally, we provide evidence that the deleterious dys-
function of CITED2 in vivo, may be surpassed by the
transient exposure of the embryos at very early stages of
development with exogenous of proteins, such as
WNT5A and WNT11. Like for Cited2, the function of a
broader number of early cardiogenic genes may be com-
plemented by treatment with exogenous molecules.
Indeed, cardiac defects and mid-gestation lethality of Id-
null mouse embryos were also partially rescued by intra-
peritoneal injection of ESC into mouse females prior to
conception47. In those injected ESC, IGF1 and WNT5A
proteins were proposed to be responsible for complete
correction of the cardiac defects. It would be of interest to
further characterize the secretome of CITED2-
overexpressing ESC which may contain additional secre-
ted factors or exosomes with properties to compensate for
the dysfunction of genes required at early stages of car-
diogenesis. The discovery of such molecules may facilitate
the development of novel clinical strategies to limit or
prevent CHD.
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